冷冻保存胎盘组织伤口基质治疗慢性静脉性腿部溃疡的前瞻性研究
这项前瞻性单中心开放标签单臂研究纳入21例C6级慢性静脉性腿部溃疡患者,其溃疡经至少12周标准治疗(含每周多层压力治疗和局部伤口护理)未愈合。随后患者在标准治疗基础上接受人活体伤口基质(hVWM)每1–2周应用,自身对照比较。结果显示53%(16/30)溃疡完全愈合,平均治疗10.9周后溃疡面积平均减少79%,优于标准治疗。
要点
- 对标准治疗至少12周未愈的C6级静脉性腿部溃疡,加用hVWM后53%完全愈合。
- hVWM治疗溃疡面积平均减少速率为每日1.69%,标准治疗为每日0.73%。
核心结论
- 冷冻保存胎盘组织(hVWM)可改善难治性慢性静脉性腿部溃疡的愈合过程,使显著比例达到完全愈合。
- 作为辅助治疗,hVWM在难治性静脉性腿部溃疡中提供优于标准治疗的愈合率。
研究设计与样本
- 前瞻性单中心开放标签单臂研究,纳入临床C6级静脉性腿部溃疡患者。
- 所有患者溃疡经至少12周标准治疗(含每周多层压力治疗和局部伤口护理)未愈合。
- 同一患者随后在标准治疗基础上接受hVWM每1–2周应用,自身对照比较。
- 共纳入21例连续合格患者的30处静脉性腿部溃疡。
主要发现
- 所有患者均为男性,平均年龄67岁(SD ±10.8岁)。
- hVWM开始前静脉性溃疡平均面积为12.2 cm²(SD ±14.6 cm²;范围3.3–12.3 cm²)。
- 双功超声证实所有患者存在浅静脉或深静脉系统反流。
- 对标准治疗难治的静脉性腿部溃疡应用hVWM后,53%(16/30)达到完全愈合。
- 平均治疗10.9周后,伤口表面积平均减少79%(SD ±27.3%;与标准治疗相比P < .001)。
关键数值与推荐
- hVWM应用后溃疡面积平均减少速率为每日1.69%,标准治疗为每日0.73%(P = .01)。
临床怎么用
- 对于经至少12周标准治疗(含多层压力治疗和局部伤口护理)未愈合的C6级静脉性腿部溃疡,可考虑在标准治疗基础上加用hVWM。
- hVWM每1–2周应用一次,作为辅助治疗可能提高难治性静脉性腿部溃疡的愈合率。
局限性
- 单中心、开放标签、单臂设计,自身对照,可能存在偏倚。
- 样本量较小(21例患者、30处溃疡),所有患者均为男性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Chronic venous leg ulcers (VLUs) affect up to 2% of the general population, resulting in a significant socioeconomic burden. Placental tissue that contains mesenchymal stem cells and active growth factors has been shown to be beneficial in healing of chronic wounds. We compared the efficacy of a human viable wound matrix (hVWM) of cryopreserved placental tissue for the treatment of refractory VLUs with standard therapy. METHODS: This prospective single-center open-label single-arm study enrolled patients with Clinical, Etiology, Anatomy, and Pathophysiology clinical class C6 VLUs. The ulcers of all enrolled patients had failed to heal after a trial of standard therapy of at least 12 weeks, which included weekly multilayer compression therapy along with local wound care. The same patients subsequently received application of hVWM (Grafix; Osiris Therapeutics, Columbia, Md) every 1 to 2 weeks in addition to standard therapy. Healing with hVWM therapy was then compared with standard therapy, with each patient serving as his own control. RESULTS: There were 30 VLUs in 21 consecutive eligible patients who were enrolled in the study. All patients were men with an average age of 67 years (standard deviation [SD], ±10.8 years), and the average area of venous ulcers before hVWM initiation was 12.2 cm2 (SD, ±14.6 cm2; range, 3.3-12.3 cm2). Duplex ultrasound confirmed superficial or deep system venous reflux in all patients. Complete ulcer healing was achieved in 53% (16/30) of VLUs refractory to standard therapy after application of hVWM. There was a mean reduction in wound surface area by 79% (SD, ±27.3%; P < .001 compared with standard therapy) after a mean treatment time of 10.9 weeks. Eighty percent of VLUs were reduced in size by half compared with 25% with standard therapy (P < .001). The mean rate of reduction in ulcer area after hVWM applications was 1.69% per day vs 0.73% per day with standard therapy (P = .01). CONCLUSIONS: Cryopreserved placental tissue (hVWM) improves healing processes to achieve complete wound closure in a significant proportion of chronic VLUs refractory to standard therapy. Adjunctive therapy with hVWM provides superior healing rates in refractory VLUs.
引用
- Farivar BS, Toursavadkohi S, Monahan TS, et al. Prospective study of cryopreserved placental tissue wound matrix in the management of chronic venous leg ulcers. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 30621916. doi:10.1016/j.jvsv.2018.09.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。